Dr Bill Nelson talks with Dr Matthias Holdhoff about the treatment of brain cancer and a significant FDA approval of a new drug treatment for a type of brain cancer, called low-grade glioma. The drug, called vorasidenib, is a targeted cancer therapy that works by inhibiting the activity of a mutated gene called IDH, slowing the growth of the cancer. Read more here 

Dr Bill Nelson speaks with Robin Hopkins, the author of What Happens Now?, and Dr Tom Smith about how we can help children comprehend a cancer diagnosis in a loved one and encourage an open dialogue about their feelings and emotions.

Download What Happens Now? for free

Dr Akila Viswanathan speaks with Dr Charles Thomas from the Dartmouth Cancer Center and Dr Ethan Ludmir from the MD Anderson Cancer Center about the design, execution and implementation of clinical trials for Seminars in Radiation Oncology.

Dr Akila Viswanathan talks with Dr Daniel Low, Vice Chair of Medical Physics Research and Innovation at UCLA Health, about MR Guided Radiation Therapy for Seminars in Radiation Oncology.

Dr Akila Viswanathan talks to Dr David Kirsch from the Princess Margaret Cancer Centre/University Health Network about treating soft tissue sarcomas for Seminars in Radiation Oncology.

Dr Bill Nelson talks to Dr Ken Kinzler, cancer researcher and Co-Director of Ludwig Cancer Research at Johns Hopkins, about his work in cancer genetics, the creation of screening tests for early detection and the future of personalized medicine.

Dr Bill Nelson talks to Terri Conneran, the founder of KRAS Kickers, about the discovery of biomarkers, targeted treatments and her advocacy for patients across all cancer types.

Dr Bill Nelson talks with Dr Clayton Yates about the evolution of his research into the genetics of ancestry.

Dr Bill Nelson talks to Dr Rick Jones and Michael McCormick about their new book Rogue Cells: A Conversation on the Myths and Mysteries of Cancer. The book offers a blend of science and humor to help make the complexities of a cancer diagnosis more accessible to patients and their care partners. Learn more about the book here.

Dr Bill Nelson speaks with Christy Wyskiel, the Executive Director of Johns Hopkins Technology Ventures, about the journey scientific discoveries take on their way to becoming life-saving treatments and the role JHTV plays in commercializing medical innovations.